BioXcel Therapeutics: Outpatient Trial Expected to Enroll About 200 Patients With Agitation Associated With Bipolar Disorder or Schizophrenia
BioXcel Therapeutics:门诊试验预计将招收约200名与躁郁症或精神分裂症相关的焦虑症患者
BioXcel Therapeutics: Outpatient Trial Expected to Enroll About 200 Patients With Agitation Associated With Bipolar Disorder or Schizophrenia
BioXcel Therapeutics:门诊试验预计将招收约200名与躁郁症或精神分裂症相关的焦虑症患者
使用浏览器的分享功能,分享给你的好友吧